Exclusive: Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources [Reuters]
Baxter International Inc. (BAX)
Last baxter international inc. earnings: 4/30 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
investor.baxter.com
Company Research
Source: Reuters
those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc (BAX.N) , according to people familiar with the matter. The divestment, which the sources said could fetch more than $4 billion, would help Baxter pay down debt following its $10.5 billion acquisition of medical device maker Hill-Rom Holdings in 2021. Baxter, which has a market value of $19 billion, had total debt of $16.6 billion as of the end of December. Private equity firms, including KKR & Co (KKR.N) and Carlyle Group (CG.O) , have also expressed interest in the Baxter business, the sources said. Other bidders could still emerge, they added. The sources requested anonymity because the matter is confidential. Baxter, Thermo Fisher and KKR declined to comment. Celltrion and Carlyle did not immediately respond to requests for comment. Baxter said in January it was exploring alternatives for its biopharma solutions business and would also spin off its kidney care units
Show less
Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAX alerts
High impacting Baxter International Inc. news events
Weekly update
A roundup of the hottest topics
BAX
News
- Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes [Yahoo! Finance]Yahoo! Finance
- Baxter to Host Annual Meeting of Stockholders in Virtual FormatBusiness Wire
- Global Local Anesthesia Drugs Market Forecast Reveals High Demand and Expansion by 2029 [Yahoo! Finance]Yahoo! Finance
- Generic Injectables Market Forecast to Reach $90.9 Billion by 2032: Oncology Therapeutic Areas and North America Dominates [Yahoo! Finance]Yahoo! Finance
- Global Local Anesthesia Drugs Market Set for Continued Growth: New Research Highlights Trends and Opportunities [Yahoo! Finance]Yahoo! Finance
BAX
Earnings
- 2/8/24 - Beat
BAX
Sec Filings
- 3/27/24 - Form DEFA14A
- 3/25/24 - Form DEFA14A
- 3/25/24 - Form DEF
- BAX's page on the SEC website